CXT fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Carmat SA is a medtech that designs, manufactures and markets the Aeson artificial heart. It focuses on Aeson to make the first alternative to a heart transplant, and thus provide a therapeutic solution for people suffering from end-stage biventricular heart failure. The company was founded by Pouletty Philippe and Alain Carpentier on June 25, 2008 and is headquartered in Vélizy Villacoublay, France.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
CXT does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company